74 related articles for article (PubMed ID: 21383611)
1. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases.
Wang WL; Soslow R; Hensley M; Asad H; Zannoni GF; de Nictolis M; Branton P; Muzikansky A; Oliva E
Am J Surg Pathol; 2011 Apr; 35(4):522-9. PubMed ID: 21383611
[TBL] [Abstract][Full Text] [Related]
2. The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.
Fadare O; Fard EV; Bhargava R; Desouki MM; Hanley KZ; Ip PPC; Li JJX; Lu B; Medeiros F; Ng JHY; Parkash V; Pinto A; Quick CM; Skala SL; Tokuyama M; Turashvili G; Wei CH; Xing D; Zheng W; Soong TR; Howitt BE
Am J Surg Pathol; 2024 May; 48(5):570-580. PubMed ID: 38512100
[TBL] [Abstract][Full Text] [Related]
3. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study.
Grimaudo MS; Renne SL; Colombo P; Giordano L; Gennaro N; Laffi A; Cariboni U; Cananzi FCM; Ruspi L; Santoro A; Bertuzzi AF
Hum Pathol; 2024 Jan; 143():17-23. PubMed ID: 38000682
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH
Cancer; 2013 Apr; 119(8):1555-61. PubMed ID: 23335221
[TBL] [Abstract][Full Text] [Related]
6. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
7. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
Major FJ; Blessing JA; Silverberg SG; Morrow CP; Creasman WT; Currie JL; Yordan E; Brady MF
Cancer; 1993 Feb; 71(4 Suppl):1702-9. PubMed ID: 8381710
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.
Hensley ML; Miller A; O'Malley DM; Mannel RS; Behbakht K; Bakkum-Gamez JN; Michael H
J Clin Oncol; 2015 Apr; 33(10):1180-5. PubMed ID: 25713428
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit.
Otsuki A; Watanabe Y; Nomura H; Futagami M; Yokoyama Y; Shibata K; Kamoi S; Arakawa A; Nishiyama H; Katsuta T; Kudaka W; Shimada M; Sato N; Kotera K; Katabuchi H; Yaegashi N
Int J Gynecol Cancer; 2015 Jan; 25(1):92-7. PubMed ID: 25347097
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.
Hensley ML; Barrette BA; Baumann K; Gaffney D; Hamilton AL; Kim JW; Maenpaa JU; Pautier P; Siddiqui NA; Westermann AM; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S61-6. PubMed ID: 25341583
[TBL] [Abstract][Full Text] [Related]
12. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.
Amant F; Floquet A; Friedlander M; Kristensen G; Mahner S; Nam EJ; Powell MA; Ray-Coquard I; Siddiqui N; Sykes P; Westermann AM; Seddon B
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S67-72. PubMed ID: 25033257
[TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis and treatment of uterine sarcomas.
Dizon DS; Birrer MJ
Discov Med; 2014 Jun; 17(96):339-45. PubMed ID: 24979254
[TBL] [Abstract][Full Text] [Related]
14. Management of advanced uterine leiomyosarcoma.
Hyman DM; Grisham RN; Hensley ML
Curr Opin Oncol; 2014 Jul; 26(4):422-7. PubMed ID: 24840518
[TBL] [Abstract][Full Text] [Related]
15. Current and future options in the management and treatment of uterine sarcoma.
El-Khalfaoui K; du Bois A; Heitz F; Kurzeder C; Sehouli J; Harter P
Ther Adv Med Oncol; 2014 Jan; 6(1):21-8. PubMed ID: 24381658
[TBL] [Abstract][Full Text] [Related]
16. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
Ricci S; Giuntoli RL; Eisenhauer E; Lopez MA; Krill L; Tanner EJ; Gehrig PA; Havrilesky LJ; Secord AA; Levinson K; Frasure H; Celano P; Fader AN
Gynecol Oncol; 2013 Dec; 131(3):629-33. PubMed ID: 24016408
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
ESMO / European Sarcoma Network Working Group
Ann Oncol; 2012 Oct; 23 Suppl 7():vii92-9. PubMed ID: 22997462
[No Abstract] [Full Text] [Related]
18. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
Cantrell LA; Havrilesky L; Moore DT; O'Malley D; Liotta M; Secord AA; Nagel CI; Cohn DE; Fader AN; Wallace AH; Rose P; Gehrig PA
Gynecol Oncol; 2012 Oct; 127(1):22-6. PubMed ID: 22727985
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
20. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
